5th International Cannabinoid-Derived Pharmaceuticals Summit
Unlock the Pharmaceutical Potential of Cannabinoids
jade faulkner
cannabinoid, cannabis, cannabis pharma, cdb, thc
0 Comment
Unlock the Pharmaceutical Potential of Cannabinoids
Phil Taylor
cannabis, Epidyolex, epilepsy, EU, GW Pharma, Jazz Pharmaceuticals, rare disease
0 Comment
News/ News/ Sales and Marketing
Phil Taylor
cannabis, Epidiolex, GW Pharma, Jazz Pharmaceuticals, M&A
0 Comment
Richard Staines
Bayer, cannabis, GW Pharmaceuticals, market access, multiple sclerosis, NICE
0 Comment
R&D/ Views & Analysis/ Views and analysis
mike.hammerton@pharmaphorum.com
cannabis, CBD, medical cannabis
0 Comment
Market Access/ Views & Analysis/ Views and analysis
mike.hammerton@pharmaphorum.com
cannabis, CBD, medical cannabis
0 Comment
George Underwood
addiction, cannabis, opioid, pain
0 Comment
Joy Persaud
cannabis, market access, medical cannabis, NHS
0 Comment